Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 45.10
-0.31 (-0.68%)
At close: Feb 13, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 4.47 billion as of February 13, 2026. Its market cap has increased by 63.41% in one year.
Market Cap
4.47B
Enterprise Value
3.66B
Revenue
23.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.10
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 4.47B, an increase of 49.83%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.50B | -7.65% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hefei Lifeon Pharmaceutical | 5.05B |
| Assure Tech (Hangzhou) | 5.03B |
| Beijing Scitop Bio-tech | 4.89B |
| Pulike Biological Engineering | 4.79B |
| Innovita Biological Technology | 4.77B |
| Obio Technology (Shanghai) Corp. | 4.51B |
| Guanhao Biotech | 4.14B |
| Zhejiang Shouxiangu Pharmaceutical | 4.11B |